Form D · Pharmaceuticals
LP Investors, LLC
Fairfield, NJ · CIK 0001727992
Offering snapshot reported Jan 12, 2018 · SEC filing
- Reported sold
- $40M Offering amount: $40M
- Investors reported
- 32 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 28, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 12, 2018 | Initial | $39,999,994 | No comparison | 32 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-303162
Source: Form D, filed Jan 12, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ronald Gold | Director, Executive |
| Steven M. Goldman | Director |
| Rasik Gondalia | Director, Executive |
| Nikhil Puri | Director |
| David Seltzer | Director |
| Christopher Semple | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3 Oak Road
Fairfield, NJ, 07004
Fairfield, NJ, 07004